Inicio>>Signaling Pathways>> Proteases>> Acyltransferase>>GOAT-IN-1

GOAT-IN-1

Catalog No.GC31080

GOAT-IN-1 es un inhibidor de la grelina O-aciltransferasa (GOAT), que podrÍa ser Útil para la profilaxis o el tratamiento de la obesidad, diabetes, hiperlipidemia, hÍgado graso metabÓlico no alcohÓlico, esteatohepatitis, sarcopenia, control del apetito, alcohol/ dependencia de narcÓticos, enfermedad de Alzheimer, enfermedad de Parkinson, demencia cerebrovascular, apoplejÍa cerebral, infarto cerebral, enfermedad cardÍaca, algunos tipos de tumores.

Products are for research use only. Not for human use. We do not sell to patients.

GOAT-IN-1 Chemical Structure

Cas No.: 1452473-54-9

Tamaño Precio Disponibilidad Cantidad
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

GOAT-IN-1 is an inhibitor of ghrelin O-acyltransferase (GOAT), which could be useful for the prophylaxis or treatment of obesity, diabetes, hyperlipidemia, metabolic, non-alcoholic fatty liver, steatohepatitis, sarcopenia, appetite control, alcohol/narcotic dependence, Alzheimer's disease, Parkinson's disease, cerebrovascular dementia, cerebral apoplexy, cerebral infarction, cardic disease, some kind of tumors.

The inhibitory activity of GOAT-IN-1 (Example 16) for human GOAT is 101% with the concentration of 10 μM[1].

[1]. WO 2013125732.

Reseñas

Review for GOAT-IN-1

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GOAT-IN-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.